Skip Navigation LinksHome > March 2012 - Volume 40 - Issue 3 > Haloperidol prophylaxis decreases delirium incidence in elde...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e3182376e4f
Feature Articles

Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial*

Wang, Wei MD; Li, Hong-Liang MD; Wang, Dong-Xin MD, PhD; Zhu, Xi MD; Li, Shuang-Ling MD; Yao, Gai-Qi MD; Chen, Kai-Sheng MD; Gu, Xiu-E RN, BSN; Zhu, Sai-Nan MS

Collapse Box

Abstract

Objectives: To evaluate the efficacy and safety of short-term low-dose intravenous haloperidol for delirium prevention in critically ill elderly patients after noncardiac surgery.

Design: Prospective, randomized, double-blind, and placebo-controlled trial in two centers.

Setting: Intensive care units of two large tertiary teaching hospitals.

Patients: Four hundred fifty-seven patients 65 yrs or older who were admitted to the intensive care unit after noncardiac surgery.

Intervention: Haloperidol (0.5 mg intravenous bolus injection followed by continuous infusion at a rate of 0.1 mg/h for 12 hrs; n = 229) or placebo (n = 228) was randomly administered from intensive care unit admission.

Measures: The primary end point was the incidence of delirium within the first 7 days after surgery. Secondary end points included time to onset of delirium, number of delirium-free days, length of intensive care unit stay, all-cause 28-day mortality, and adverse events. Delirium was assessed using the confusion assessment method for the intensive care unit.

Results: The incidence of delirium during the first 7 days after surgery was 15.3% (35/229) in the haloperidol group and 23.2% (53/228) in the control group (p = .031). The mean time to onset of delirium and the mean number of delirium-free days were significantly longer (6.2 days [95% confidence interval 5.9−6.4] vs. 5.7 days [95% confidence interval 5.4−6.0]; p = .021; and 6.8 ± 0.5 days vs. 6.7 ± 0.8 days; p = .027, respectively), whereas the median length of intensive care unit stay was significantly shorter (21.3 hrs [95% confidence interval 20.3−22.2] vs. 23.0 hrs [95% confidence interval 20.9–25.1]; p = .024) in the haloperidol group than in the control group. There was no significant difference with regard to all-cause 28-day mortality between the two groups (0.9% [2/229] vs. 2.6% [6/228]; p = .175). No drug-related side effects were documented.

Conclusions: For elderly patients admitted to intensive care unit after noncardiac surgery, short-term prophylactic administration of low-dose intravenous haloperidol significantly decreased the incidence of postoperative delirium. The therapy was well-tolerated.

© 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.